Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies

Sponsor
Dow University of Health Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT05989386
Collaborator
(none)
200
1
2
13
15.4

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the outcomes of High-volume saline irrigation vs Povidone-iodine solution cleaning of the intraoperative incision wound in preventing superficial surgical site infections in patients undergoing emergency laparotomies. The main question it aims to answer are:

  • Incidence of SSI after intervention

  • Length of hospital stay

Participants will be randomly assigned to two groups receiving either of the two groups:

Group A: 1000ml of IOWI with saline solution prior to incision closure Group B: The incisional wound will be closed conventionally without irrigation.

Researchers will compare groups A( experimental group) and B (control group) to compare the incidence of superficial surgical site infections after intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 0.9% saline solution
  • Procedure: Povidone-iodine Swab
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of Intraoperative Incision Wound in Preventing Surgical Site Infections in Emergency Laparotomies: A Randomized Controlled Trial
Actual Study Start Date :
Apr 29, 2023
Anticipated Primary Completion Date :
Apr 29, 2024
Anticipated Study Completion Date :
May 29, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A

Intra-operative wound irrigation of 0.9% solution saline solution

Procedure: 0.9% saline solution
During emergency laparotomy, after the primary surgical procedure. the sheath will be sutured and the incision site will then be irrigated with three rounds of 1 liter of 0.9% saline solution, which will be completely aspirated before the closure of the incisional wound in experimental group.

Active Comparator: Group B

No intra-operative wound lavage done

Procedure: Povidone-iodine Swab
No intra-operative wound lavage done, and wound would be cleaned with povidone doused swab.
Other Names:
  • Control
  • Outcome Measures

    Primary Outcome Measures

    1. Incidence of Superficial Surgical site infections [Upto 4 weeks post-operatively]

      Development of Superficial Surgical Site Infection as determined by the CDC guidelines.

    Secondary Outcome Measures

    1. Length of Hospital Stay [Upto 4 weeks post-operatively]

      Number of in-hospital days (from time of admission to time of discharge)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • • Patients undergoing emergency laparotomy under the care of surgical-6 unit of Dr. Ruth K. M. Pfau Civil Hospital Karachi

    • The age of patients should be between 18-60 years old.

    Exclusion Criteria:
    • Diabetic patients

    • Immune-suppressed patients

    • Patients taking steroids

    • Patients undergoing chemo-radiotherapy.

    • Pregnant females

    • Previous abdominal surgery within the last 30 days.

    • Presence of concurrent abdominal wall infections.

    • Trauma Laparotomies

    • Large Bowel perforations

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dr. Ruth K. M. Pfau Civil Hospital Karachi Karachi Sindh Pakistan 74400

    Sponsors and Collaborators

    • Dow University of Health Sciences

    Investigators

    • Principal Investigator: Omer Bin Khalid, Assist Prof., Dr. Ruth F. M. Pfau Civil Hospital Karachi
    • Study Director: Imrana Zulfikar, Professor, Dr. Ruth F. M. Pfau Civil Hospital Karachi

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Omer bin khalid, Principal Investigator (Assistant Professor), Dow University of Health Sciences
    ClinicalTrials.gov Identifier:
    NCT05989386
    Other Study ID Numbers:
    • 2811
    First Posted:
    Aug 14, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2023